Fatemeh Safari

Dr. Fatemeh Safari

Shiraz University of Medical Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2019 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
FSFatemeh Safari
Fatemeh Safari
KZKhadijeh Zare
Khadijeh Zare
MNManica Negahdaripour
Manica Negahdaripour
MBMazyar Barekati-Mowahed
Mazyar Barekati-Mowahed
YGYounes Ghasemi
Younes Ghasemi
CRISPR and CRISPR-associated (Cas) protein, as components of microbial adaptive immune system, allows biologists to edit genomic DNA in a precise and specific way. CRISPR-Cas systems are classified into two main classes and six types. Cpf1 is a putative type V (class II) CRISPR effector, which can be programmed with a CRISPR RNA to bind and cleave complementary DNA targets. Cpf1 has recently emerged as an alternative for Cas9, due to its distinct features such as the ability to target T-rich motifs, no need for trans-activating crRNA, inducing a staggered double-strand break and potential for both RNA processing and DNA nuclease activity. In this review, we attempt to discuss the evolutionary origins, basic architectures, and molecular mechanisms of Cpf1 family proteins, as well as crRNA designing and delivery strategies. We will also describe the novel Cpf1 variants, which have broadened the versatility and feasibility of this system in genome editing, transcription regulation, epigenetic modulation, and base editing. Finally, we will be reviewing the recent studies on utilization of Cpf1as a molecular tool for genome editing.

26 November 2019 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
FSFatemeh Safari
Fatemeh Safari
GHGholamreza Hatam
Gholamreza Hatam
ABAbbas Behzad Behbahani
Abbas Behzad Behbahani
VRVahid Rezaei
Vahid Rezaei
MBMazyar Barekati‑Mowahed
Mazyar Barekati‑Mowahed
FKFarzaneh Khademi
Farzaneh Khademi

28 September 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KGKianoush Ghiasvand
Kianoush Ghiasvand
MAMehdi Amirfazli
Mehdi Amirfazli
PMParvaneh Moghimi
Parvaneh Moghimi
FSFatemeh Safari
Fatemeh Safari
MTMohammad Ali Takhshid
Mohammad Ali Takhshid

11 January 2022 in Biological Research
Verified
Journal Article
Open access
PDF file
FSFatemeh Safari
Fatemeh Safari
BABahman Akbari
Bahman Akbari
Background: Chinese hamster ovary cell line has been used routinely as a bioproduction factory of numerous biopharmaceuticals. So far, various engineering strategies have been recruited to improve the production efficiency of this cell line such as apoptosis engineering. Previously, it is reported that the caspase-7 deficiency in CHO cells reduces the cell proliferation rate. But the effect of this reduction on the CHO cell productivity remained unclear. Hence, in the study at hand the effect of caspase-7 deficiency was assessed on the cell growth, viability and protein expression. In addition, the enzymatic activity of caspase-3 was investigated in the absence of caspase-7. Results: Findings showed that in the absence of caspase-7, both cell growth and cell viability were decreased. Cell cycle analysis illustrated that the CHO knockout (CHO-KO) cells experienced a cell cycle arrest in G2/M phase. This cell cycle arrest resulted in a 1.7-fold increase in the expression of luciferase in CHO-KO cells compared to parenteral cells. Furthermore, in the apoptotic situation the enzymatic activity of caspase-3 in CHO-KO cells was approximately 3 times more than CHO-K1 cells. Conclusions: These findings represented that; however, caspase-7 deficiency reduces the cell proliferation rate but the resulted cell cycle arrest leads to the enhancement of recombinant protein expression. Moreover, increasing in the caspase-3 enzymatic activity compensates the absence of caspase-7 in the caspase cascade of apoptosis.

15 April 2020 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
FSFatemeh Safari
Fatemeh Safari
SFSafar Farajnia
Safar Farajnia
YGYounes Ghasemi
Younes Ghasemi
NZNosratollah Zarghami
Nosratollah Zarghami
MBMazyar Barekati‑Mowahed
Mazyar Barekati‑Mowahed
Purpose: CRISPR/Cas9 gene editing technology has revolutionized gene manipulation by providing the opportunity of gene knock out/in, transcriptional modification and base editing. The application of this system extended into different eras of biology, from cell development to animal modeling. Various generations of CRISPR technology have been developed to make genome editing easy which resulted in rapid protocols for amelioration of a large genome. Methods: we established a simple protocol for gene manipulation in Chinese hamster ovary (CHO) cells to achieve a Caspase 7 deficient cell line by using combination of all-in-one CRISPR technology and CRISPR/ Cas9 homology-independent targeted integration (CRISPR HITI). Results: the findings of this study indicated that using CRISPR knocking in/out technology facilitates genomic manipulation in CHO cells. Integration of EGFP in target locus of caspase 7 gene made the selection of knockout CHO cell line easy which achieved by cell sorting and single-cell cloning. Conclusion: this system introduces an effective targeting strategy for multiplex genome engineering, coinciding gene integration which simplified the selection of desired genomic characteristics.

29 March 2024 in Biotechnology and Bioprocess Engineering
Verified
Journal Article
Closed access
PDF file
SSSoofia Sorourian
Soofia Sorourian
ABAbbas Behzad Behbahani
Abbas Behzad Behbahani
GDGholamreza Rafiei Dehbidi
Gholamreza Rafiei Dehbidi
FZFarahnaz Zare
Farahnaz Zare
SFSafar Farajnia
Safar Farajnia
FSFatemeh Safari
Fatemeh Safari